Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Prosensa Holding (RNA)

Add to Watchlists
Create an Alert
5.85 -0.05  -0.85% NASDAQ Apr 24, 2:25PM BATS Real time Currency in USD
View Full Chart
RNA Price Chart
View All Events

RNA Events

Date Type Description
Jan 23 Misc EGM Event for Prosensa Holding N.V.
View All Performance Charts

RNA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Prosensa Holding is up N/A over the last year vs S&P 500 Total Return up 21.38%, Sarepta Therapeutics up 23.25%, and Actelion up 67.22%.

Get Quote for

Portfolio Strategies Featuring RNA

Did Prosensa Holding make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

RNA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Netherlands
  • Headquarters State/Province: N/A
  • Incorporation Country: Netherlands
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Prosensa Holding N.V. is engaged in the discovery and development of RNA-modulating therapeutics for the treatment of rare genetic disorders. Its product candidates includes drisapersen and PRO044.

Recent Quotes

Symbol Price Chg Chg % Market Cap
RNA 5.85 -0.05 -0.85% 210.21M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.